Clinical trial
Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation…
NCT00280761 · UNC Lineberger Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00280761 |
|---|---|
| Title | Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy |
| Official title | A Biologic Study of Global Gene Expression, NF-Kappa B and p53 in Adenocarcinoma of the Rectum. |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, 5-fluorouracil, Surgical Resection, Radiation therapy |
| Enrollment | 47 |
| Start date | Dec 1, 2003 |
| Primary completion | Sep 19, 2021 |
| Completion | Sep 19, 2021 |
| First posted | Jan 23, 2006 |
| Last update posted | Aug 11, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: